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Aberrant Expression and Function of Gap
Junctions during Carcinogenesis
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Gap junctional intercellular communication plays a key role in the maintenance of homeostasis in
multicellular organisms. Reflecting deranged homeostasis in cancer cells, most transformed or cancerous
cells show aberrant gap junctional intercellular communication; they have decreased junctional com-
munication between each other and/or with surrounding normal cells. Studies with in vitro cell transfor-
mation and animal carcinogenesis models suggest an involvement ofblocked intercellular communication
in later stages of carcinogenesis. Analysis of expression of gap junction proteins (connexins) and corre-
sponding mRNA indicates that a number of regulation sites are involved in aberrant function of gap
junctions during carcinogenesis. Suppression of transformed phenotypes is often seen when transformed
cells are physically in contact with their normal counterparts. Some studies suggest that gap junctional
intercellular communication is involved in such tumor suppression.
Introduction
The major role of gap junctional intercellular com-
munication (GJIC) is considered to be the maintenance
ofhomeostasis inmulticellularorganisms. Gapjunctions
mediate the transfer offactors ofmolecular weight less
than 1000 from within one cell into adjacent cells. It is
believed thatthrough GJICthelevelofsecond messages
which are important for growth control is harmonized
among cells in a given tissue and that the homeostasis
of a tissue can be maintained (1,2). Aberrant growth
control vis-a-vis surroundingnormal cells is an essential
feature of cancer cells. Therefore, it has long been con-
sidered that altered GJIC might play an essential role
in carcinogenesis (2-4).
Recent studies on the structure of gap junction pro-
teins have begun to reveal the fine structure and mem-
brane topology of gap junctions. As depicted in Figure
1, a gapjunction consists oftwo connexons, each coming
from one cell. Each connexon consists of six subunits
called connexins. The connexin membrane topology is
also shown in Figure 1, and it is believed that the chain
traverses the membrane four times with the C-terminal
and N-terminal in cytoplasmic areas and two loops in
the extracellular space (5-7).
Although the schematic view presented in Figure 1
represents common features of connexins, there are
severaldifferentproteins that areexpressedindifferent
tissues. For example, connexin 32 codes for the con-
nexin molecule with a molecular weight of 32 kDa; it
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was originally isolated from the liver and is also ex-
pressed in kidney and stomach cells but not in, for ex-
ample, heart cells (8-10). On the other hand, connexin
43, which was isolated from heart cells (11), is not ex-
pressed in hepatocytes; however, it is expressed in bil-
iary epithelial cells and various fibroblasts. In addition
to these two connexins, connexin 26 has recently been
isolated as a second connexin ofthe liver (7). While the
structure ofthese connexins appearstobe similar, their
regulation may be different. For example, connexin 26
has a shorter carboxy terminus, and therefore phos-
phorylation sites for cAMP-dependent protein kinase
are absent in connexin 26 (7). Antibodies and cDNA for
these three different connexins have been prepared (7-
13) and much used in studies ofthe mechanisms offunc-
tion of gap junctions. While it has been reported that
connexin 43 and 32 can together form functional gap
junctions in Xenopus oocytes (14), it is still not known
whether such heterologous combination of connexins
can occur in somatic cells.
GJIC can be modulated at various levels (15). In ad-
dition to the usualmechanisms formodulationofprotein
synthesis, it is thought that GJIC can be modulated
after the formation of functional gap junctions. Under
certain circumstances, it is believed that the hole in a
gapjunction can be closed by twisting six connexin sub-
units (16). Recent studies also suggest that cell-to-cell
recognition may be a prerequisite for two adjacent cells
to form gap junctions. The cell-cell recognition mole-
cules includeextracellular matrix and cell adhesion mol-
ecules (15). The existence of different points of regu-
lation of GJIC is reflected by the fact that cancer cells
have GJIC alterations at different levels and that suchH. YAMASAKI
FIGURE 1. Schematic view of gap junctions in membrane lipid bi-
layers andtopology ofconnexins. While the structure andtopology
are generally considered common to various connexin molecules,
there are important differences between them which may be re-
lated to the regulation oftheir function (see text for details).
alterations occur during carcinogenesis and in various
cancer cells, as discussed below.
Cancer Cells Have Altered
Expression or Function of Gap
Junctions
The most convincing evidence for the involvement of
aberrant GJIC duringcarcinogenesis has come fromthe
fact that most, if not all, cancer cells have aberrant
GJIC. The loss of GJIC in cancer cells was first dem-
onstrated by the group ofLoewenstein and Kanno (17-
19). Many ensuing studies have confirmed that various
cancer cells have lost or decreased GJIC capacity (20-
24). However, we have recently shown that not all tu-
morigenic or transformed cells have decreased GJIC.
Forexample, BALB/c 3T3 cells transformed by various
carcinogens maintained their GJIC at levels similar to
thatofnontransformed counterparts (25-27). However,
these transformed cells did not communicate with sur-
rounding normal cells (25-27). Similar selective lack of
GJIC was observed with tumorigenic and nontumori-
genic rat liver epithelial cells (28). From these results
and others, we postulated that, for cells to become can-
cerous, they may need to lose GJIC with their sur-
rounding normal cells rather than losing their homolo-
gous GJIC (29). Such aloss ofheterologousintercellular
communication can occur by one of the following two
ways. Either a) the tumor cells may lose the means of
homologous communication between each other, in
which case it is natural to consider that they could also
not communicate heterologously with normal cells, or
b) normal cells and tumorigenic cells communicate
among themselves but not heterologously. These two
hypotheses are represented schematically in Figure 2.
WhilemostevidenceforaberrantGJIC hascomefrom
cell culture studies, it is now possible to analyze tumor
cells taken directly from animals or humans using mo-
lecularprobes. Forexample, ithas recentlybeen shown
that rat liver hepatocellular carcinoma, as well as pre-
neoplastic nodules, show a drastic decrease in connexin
gene and protein expression (12,30,31). On the other
hand, analysis of six human hepatocellular carcinomas
surgically removed from patients revealed no decrease
in levels of the mRNA for connexin 32 (the connexin
expressed in hepatocytes), but there was increased
expressionofconnexin43(32); connexin43isnotusually
expressedinhepatocytesinhumans. Whileitisnotclear
whether such aberrant expression ofconnexin 43 in he-
patocellularcarcinomacontributes to aberrantfunction,
such an aberrant expression of connexins may be as-
sociated with the malignant growth of hepatocellular
carcinomas, since all tested hepatocellular carcinomas
(1l (2)
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FIGURE 2. Selective intercellular communication and maintenance
oftransformed phenotypes-schematic view. Scheme (1) shows a
tumor in which individual cells cannot intercommunicate and thus
cannotcommunicate withthe surroundingnormalcells. Inscheme
(2), the cells in the tumor intercommunicate among themselves
but not with surrounding cells. In neither case is there commu-
nication between the tumor and the surrounding normal cells.
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have shown the increased expression ofthis particular
connexin (32).
Table 1. Inhibition of gap-junctional intercellular
communication by tumor-promoting stimuli.
Involvement of Aberrant Gap
Junctional Intercellular
Communication in Carcinogenesis
Although ample evidence suggests that GJIC is aber-
rant in cancer cells, it is not clear when such an alter-
ation occurs during the process of carcinogenesis. This
question was first asked by the groups of Trosko and
Murray; they found that the tumor-promoting phorbol
esters can reversibly inhibit GJIC between cultured
cells (33,34). This finding suggested strongly that the
block ofintercellular communication plays an important
role in the tumor-promotion stage of carcinogenesis.
The hypothesis is that, at the initiation phase, there is
a genetic alteration that creates a dormant, initiated
cell. Such an initiated cell may be dormant because sur-
rounding normal cells can suppress the expression or
expansion oftheinitiated cellsthrough controlbyGJIC.
A block of GJIC by tumor-promoting agents liberates
the initiated cells from this growth control so that they
expand clonally. It has subsequently become apparent
that many, though not all, tumor-promoting agents can
inhibit GJIC. This has been found using different meth-
odsformeasurement ofintercellular communication and
different types of cells. These findings are summarized
in Table 1.
Although the molecular mechanisms by which tumor-
promoting agents block GJIC are largely unknown,
some information is available on how phorbol esters
block communication. It has been suggested that phor-
bol-ester-mediated blockofGJICinvolvestheactivation
of protein kinase C (35,36). While connexin molecules
have phosphorylation sites for protein kinase C (37), it
is not known whether phosphorylation of connexin by
this enzyme is related to the inhibition of the function
ofconnexin. We have recently shown thatphorbol ester
treatment of cultured cells does not decrease the level
of connexin mRNA. The level of connexin mRNA was
not changed during the inhibition and the downregu-
lation period of 12-0-tetradecanoyl phorbol 13-acetate
(TPA) effects. On the other hand, there was a drastic
decrease in gap junction structures after TPA treat-
ment, as demonstrated with connexin-specific antibody
staining. The gap junction structures revealed by con-
nexin antibody reappeared when the TPA effect on gap
junctional communication diminished. In other words,
there was a close correlation between the loss of func-
tion of gap junctions and disappearance of immuno-
stainable connexin molecules, suggesting posttransla-
tional regulation of gap junctions. These findings are
consistent with our previous results which suggested
that regulation of gap junctional communication by
phorbol esters is a posttranslational event (38).
Using a BALB/c 3T3 cell transformation system, we
have provided several lines of evidence that suggest
that decreased GJIC is indeed related tothe laterphase
Method of communication
measurementa
Metabolic cooperation
[3H]uridine metabolites
transfer
HGPRT+/HGPRT-
ASS-/ASL-
AK+/AK-
Electrical coupling
Dye transfer
Microinjection
Photobleaching
Scrape loading
Gap junction structure analysis
Electron microscope
Gel electrophoresis analysis
Analysis with gap junction
antibody
Gap junction gene expression
Connexin 32 mRNA level
Examples ofpromoting stimulus
Phorbol esters, chlordane
Phorbol esters and many other
tumor-promoting agents
Phorbol esters, DDT
Phorbol esters
Phorbol esters
Skin wounding
Phorbol esters, cigarette smoke
condensate, PCB,
diacylglycerol, and certain
other tumor-promoting agents
Partial hepatectomy
TPA, dieldrin, PBB
TPA, dieldrin, and other tumor-
promoting agents
Phorbol esters, mezerein
Phenobarbital, DDT
Phorbol esters
Partial hepatectomy
Phenobarbital
Partial hepatectomy
aHGPRT, hypoxanthineguaninephosphoribosyltransferase; ASS-,
argininosuccinate synthetase-deficient; ASL-, argininosuccinate
lyase-deficient; AK, adenosine kinase.
ofcell transformation. For example, a) enhancement of
cell transformation mediated by phorbol esters or dia-
cylglycerol is related to inhibition ofGJIC in these cell
lines (39,40); b) antitumor-promoting agents such as re-
tinoic acid, cAMP, and glucocorticoids can antagonize
phorbol-ester-mediated inhibition of intercellular com-
munication and can inhibit cell transformation in these
cell lines (41,42); c) a BALB/c 3T3 cell variant that is
susceptible to chemicals or UV light-mediated cell
transformationlostGJIC whenthecellsreached culture
confluence, whileothercelllinesdidnot, suggestingthat
the loss of GJIC in the cell transformation-susceptible
cell line is related to its high transformation frequency
(43).
On the other hand, there are also several lines of
evidence that suggest that block of GJIC is not neces-
sarily related to enhanced cell transformation. For ex-
ample, transforminggrowth factor(TGF)-P, 2,3,7,8-te-
trachlorodibenzo-p-dioxin (TCCD), and okadaic acid
have been shown to enhance cell transformation of
BALB/c 3T3 cells or C3H1OT1/2 cells (26,44,45). These
agents, however, did notblock GJIC in the same target
cells. While it is possible that these tumor-promoting
agents block GJIC only locally, includinginitiated cells,
it is more likely that they act by different mechanisms
and that these agents enhance transformation by mech-
anisms notinvolvingblockofGJIC. Analysis ofsamples
during tumor progression suggests that block of GJIC
is also a later event in animal carcinogenesis. For ex-
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ample, the analysis ofcell lines established from differ-
ent stages of mouse skin carcinogenesis revealed that
there is a progressive decrease ofGJIC as the stage of
carcinogenesis advances (24). Similarly, analysis of gap
junction proteins and mRNA levels during liver carcin-
ogenesis has revealed the progressive decrease in their
expression from normal to preneoplastic foci, preneo-
plastic nodules, and finally to hepatocellular carcinoma
(31; unpublished results).
Gap Junctional Intercellular
Communication and Oncogenes
Considering the importance of signal transduction
within cells, it is conceivable that a membrane event
such as GJIC and nuclear factors such as cellular onc-
ogenes influence each otherand that such an interaction
may play an important role in carcinogenesis. Earlier
studies ontherelationshipbetween oncogenes andGJIC
examined whether oncogenes can modulate GJIC. Such
studies have shown that certain viral oncogenes such
asthe v-src gene canindeed inhibit GJIC (46-48). Other
oncogenes have also been shown to inhibit GJIC. How-
ever, some laboratories, including ours, have found no
inhibitoryeffect ofsome ofthese oncogenes on gapjunc-
tional communication. These results are summarized in
Table 2.
In collaboration with M. Bignami and F. Tato, we
examined the relationship between v-onc expression,
focus formation, and GJIC in NIH 3T3 cells (49). When
cells containing v-myc or v-fos genes were co-cultured
with normal cells, they communicated heterologously
and did not form distinct foci on the monolayer of the
normal cells. When a GJIC blocker, namely, a phorbol
ester, was added to the co-culture, transformed foci
appeared. Ontheotherhand, ras- orsrc-containingcells
did form distinct foci over a monolayer of normal cells
and did not show heterologous communication with sur-
rounding normal cells.
Theseresults suggestthatGJICbetweennormalcells
and oncogene-containing cells can influence oncogene-
mediated expression oftransformed phenotypes. How-
ever, we could not determine whether GJIC was mod-
ulating oncogene expression or viral oncogenes were
modulating GJIC. Since viral oncogenes by themselves
did not modulate homologous communication in trans-
fected cells, it is more likely that heterologous com-
munication modulated oncogene expression.
Possible Role of Gap Junctional
Intercellular Communication in
Tumor Suppression
If aberrant GJIC plays an important role in carcin-
ogenesis, it means, from the other side ofthe coin, that
normal GJIC can act in a tumor-suppressive role. As
summarized in Table 3, there are several lines of evi-
dence that direct contact oftransformed cells with nor-
mal cells can indeed suppress transformed phenotypes.
Earlier studies did not relate this direct cell contact-
mediated suppression of transformed phenotypes with
GJIC per se. However, some recent studies have re-
vealed a close correlation between tumor suppression
and GJIC between transformed and normal cells. As
described above, we have shown that transformed
BALB/c 3T3 cells do not communicate with surrounding
Table 2. Effect of oncogenes on homologous and heterologous gap junctional intercellular communication.
Homologous Heterologous
Oncogene Cells communicationa communicationb Reference
v-src NRK 4 NT (46)
NIH 3T3 4 NT (48)
Quail and chick
embryo fibroblasts 4 NT (47)
NIH 3T3 - (49)
c-src NIH 3T3 4 NT (56)
v-ras NIH 3T3 - (49)
EJ-rasH BALB/c 3T3 - (27)
Rat liver epithelia + (57)
cell line IAR20
Rat liver epithelia 4 NT (58)
cell line
v-myc NIH 3T3 + (49)
v-fos NIH 3T3 + (unpublished data)
v-mos C3H1OT1/2 or 4 NT (59)
PyMT Rat F cells 4 NT (60)
NIH 3T3 (unpublished data)
PyLT NIH 3T3 + (unpublished data)
SV40T Human hepatocytes 4 NT (unpublished data)
Human keratinocytes 4 NT (unpublished data)
Human fibroblasts 4 4 (61)
aHomologous communication is the communication among oncogene-containing cells, and their communication capacity was compared with
that ofnormal counterparts. (4) decreased; (-*) no change; ( T ) enhanced.
bHeterologous communication is the presence (+), absence (-), or decrease (4) of communication between oncogene-containing cells and
normal cells measured in co-culture of these two types of cells. NT, not tested.
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Table 3. Suppression of transformed phenotypes by contact with normal counterparts.
Evidence of GJIC'
involved in the suppression Cell type Reference
Polyoma virus-BHK21 cells b (62)
SV40-Swiss 3T3 Rescue of transformed foci by croton oil (63)
Chemically transformed C3H1OT1/2 (64)
UV + TPA-transformed C3H1OT1/2 Rescue oftransformed foci by TPA (65)
Tumorigenic rat tracheal epithelial cells (in vivo (66)
transplant)
Harvey sarcoma virus-transformed mouse (67)
epidermal cells (+ dermal fibroblasts in vivo
grafting)
Chemically transformed mouse (68)
epidermal cells (68)
Chemically and virally transformed C3H1OT1/2 cells Dye transfer (50)
Chemically transformed BALB/c 3T3 cells (with Dye transfer (42)
dbcAMP, retinoic acid, glucocorticoids)
C-myc- or N-myc-transformed 3T3 cells (69)
v-myc-transformed NIH 3T3 cells (70)
v-myc-, v-fos-, PL-LT-transformed BALB/c 3T3 Dye transfer (49)
cells
'This was obtained either by adding gap junctional intercellular communication (GJIC) blocking agents (croton oil or TPA) to rescue
transformed foci or by direct measurement of GJIC between transformed and normal cells.
bNo attempt was made to relate the suppression to GJIC.
normal cells, although the transformed cells communi-
cate among themselves (25-27). However, when agents
such as cAMP, retinoic acid, and glucocorticoids were
added to culture dishes that contained already trans-
formed foci, many transformed foci disappeared (42).
There was also a resumption of GJIC between trans-
formed cells and surrounding normal cells (42). Al-
though the evidence is indirect, these results suggest
that suppression of transformed phenotypes by sur-
rounding normal cells may be due to resumption of
GJIC. Similarly, Loewenstein's group has shown that
in co-cultures of transformed and nontransformed
C3H1OT1/2 cells, transformed cell growth was sup-
pressed when there was good heterologous GJIC be-
tween transformed and nontransformed cells (50).
Studies on genetic mechanisms oftumor suppression
have revealed several genes as candidates for involve-
ment in tumor suppression. Some of these candidate
genes seem to be linked to cell-cell interaction. For ex-
ample, agenebelieved tohave atumor-suppressive role
in relation to human colorectal cancers and located on
chromosome 18 has recently been shown to have se-
quence homology to N-CAM, a cell adhesion molecule
(51). Similarly, Saito et al. (52) have determined the
structure of a putative tumor-suppressive molecule,
phospho-tyrosine phosphatase, and suggested that the
structure is very similar to that of N-CAM. Since cell
adhesion molecules are thought to play an important
role in the control ofGJIC (53), it is possible that these
putative tumor-suppressive genes may be involved in
functional regulation of GJIC.
Conclusion and Future Perspectives
Available evidence suggests that aberrant GJIC is
associated with the tumor promotion phase of carcino-
genesis and with maintenance of transformed and/or
tumorigenic phenotypes. There is also evidence that
normal GJIC may act in a tumor-suppressive role.
Since molecular probes to study GJIC have only re-
cently become available, there remains much scope for
further research on the role of GJIC in carcinogenesis
and intumor suppression. One ofthe fundamental ques-
tions we have to ask is what kind ofmolecules are going
through gapjunctions and which ofthose molecules are
important in the regulation of cell growth and differ-
entiation. So far, calcium, cAMP, and inositol triphos-
phate have been shown to pass through gap junctions
(54,55). It is believed that many other molecules are
also exchanged between cells through gap junctions.
Identification of such molecules is difficult. It is even
more difficult to identify those molecules that pass
through gapjunctions and are also important in growth
control, since these are likely to be second messengers
in signal transduction and are probably present in low
amounts.
The molecular mechanisms ofregulation ofGJIC are
not yet known. However, it is important to emphasize
the possible involvement ofcell adhesion molecules. We
found a selective intercellular communication between
transformed and nontransformed BALB/c 3T3 cells.
Since both transformed and nontransformed cells com-
municate among themselves, but not with each other,
it appears that a cell-to-cell recognition mechanism is
altered. Recently, we have introduced a gene for a cell
adhesion molecule into cells that were otherwise incap-
able of gap junction communication and found that the
transfected cells did express the cell adhesion molecule
and started to communicate, suggesting the direct con-
trolofGJICbycelladhesionmolecules. Thisalsoimplies
that it is not necessary to directly alter GJIC itself in
order to block communication; instead, blocking or al-
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teringthecell-cellrecognitionmechanismmaymodulate
GJIC. By this means, alteration of cell-cell recognition
may be an important aspect involved during carcino-
genesis.
Asemphasized above, mostavailableevidence forthe
involvement ofGJICincarcinogenesisiscircumstantial.
It is important now to investigate more directly the
relationship between GJIC and carcinogenesis. Molec-
ular probes such as expression vectors of gap junction
proteins (connexins) and cell adhesion molecules have
recently become available, which should make this pos-
sible. We expect to see rapid progress in our under-
standingbothoffundamentalaspectsofGJICregulation
and of its implication in multistage carcinogenesis.
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